Advances in the study of S100A9 in cardiovascular diseases.

Cardiovascular disease (CVD) is a group of diseases that primarily affect the heart or blood vessels, with high disability and mortality rates, posing a serious threat to human health. The causative factors, pathogenesis, and characteristics of common CVD differ, but they all involve common pathological processes such as inflammation, oxidative stress, and fibrosis. S100A9 belongs to the S100 family of calcium-binding proteins, which are mainly secreted by myeloid cells and bind to the Toll-like receptor 4 and receptor for advanced glycation end products and is involved in regulating pathological processes such as inflammatory response, fibrosis, vascular calcification, and endothelial barrier function in CVD.

Advances in Simple, Rapid, and Contamination-Free Instantaneous Nucleic Acid Devices for Pathogen Detection.

Pathogenic pathogens invade the human body through various pathways, causing damage to host cells, tissues, and their functions, ultimately leading to the development of diseases and posing a threat to human health. The rapid and accurate detection of pathogenic pathogens in humans is crucial and pressing. Nucleic acid detection offers advantages such as higher sensitivity, accuracy, and specificity compared to antibody and antigen detection methods.

Porous composite architecture bestows Fe-based glassy alloy with high and ultra-durable degradation activity in decomposing azo dye.

Since the treatment of wastewater containing azo dye presents problems worldwide, it is important to seek effective materials and technology for the purification of wastewater containing azo dye. Fe-based metallic glasses have been identified as promising materials for the decomposition of dyeing wastewater due to their high chemical activity resulting from their amorphous structure. It is imperative to further improve their degradation performance, and especially their durability, for potential application in wastewater purification.

[Long Non Coding RNA RP11-69I8.3 Expression in Acute Leukemia and Its Cinical Significance].

Objective: To investigate the expression of long non coding RNA RP11-69I8.3 in acute leukemia and its clinical significance.

Methods: lncRNA RP11-69I8.